| Sensitive detection of mono-and polyclonal ESR1 mutations in primary tumors, metastatic lesions, and cell-free DNA of breast cancer patients P Wang, A Bahreini, R Gyanchandani, PC Lucas, RJ Hartmaier, ... Clinical cancer research 22 (5), 1130-1137, 2016 | 152 | 2016 |
| Use of liposomes as drug delivery vehicles for treatment of melanoma MA Tran, RJ Watts, GP Robertson Pigment cell & melanoma research 22 (4), 388-399, 2009 | 116 | 2009 |
| Intrinsic subtype switching and acquired ERBB2/HER2 amplifications and mutations in breast cancer brain metastases N Priedigkeit, RJ Hartmaier, Y Chen, D Vareslija, A Basudan, RJ Watters, ... JAMA oncology 3 (5), 666-671, 2017 | 95 | 2017 |
| Targeting of survivin by nanoliposomal ceramide induces complete remission in a rat model of NK-LGL leukemia X Liu, L Ryland, J Yang, A Liao, C Aliaga, R Watts, SF Tan, J Kaiser, ... Blood, The Journal of the American Society of Hematology 116 (20), 4192-4201, 2010 | 93 | 2010 |
| Exome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases N Priedigkeit, RJ Watters, PC Lucas, A Basudan, R Bhargava, W Horne, ... JCI insight 2 (17), 2017 | 71 | 2017 |
| Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer RJ Hartmaier, SE Trabucco, N Priedigkeit, JH Chung, CA Parachoniak, ... Annals of Oncology 29 (4), 872-880, 2018 | 51 | 2018 |
| Therapeutic efficacy of FTY720 in a rat model of NK-cell leukemia A Liao, K Broeg, T Fox, SF Tan, R Watters, MV Shah, LQ Zhang, Y Li, ... Blood 118 (10), 2793-2800, 2011 | 50 | 2011 |
| Cysteine string protein promotes proteasomal degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) by increasing its interaction with the C terminus of … BZ Schmidt, RJ Watts, M Aridor, RA Frizzell Journal of Biological Chemistry 284 (7), 4168-4178, 2009 | 45 | 2009 |
| T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias RJ Watters, X Liu, TP Loughran Jr Leukemia & lymphoma 52 (12), 2217-2225, 2011 | 38 | 2011 |
| Targeting sphingosine-1-phosphate receptors in cancer R J Watters, HG Wang, SS Sung, T P Loughran, X Liu Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2011 | 36 | 2011 |
| Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia RJ Watters, TE Fox, SF Tan, S Shanmugavelandy, JE Choby, K Broeg, ... Leukemia & lymphoma 54 (6), 1288-1296, 2013 | 31 | 2013 |
| Development and use of ceramide nanoliposomes in cancer RJ Watters, M Kester, MA Tran, TP Loughran Jr, X Liu Methods in enzymology 508, 89-108, 2012 | 24 | 2012 |
| Frequent ESR1 and CDK pathway copy-number alterations in metastatic breast cancer A Basudan, N Priedigkeit, RJ Hartmaier, ES Sokol, A Bahreini, RJ Watters, ... Molecular Cancer Research 17 (2), 457-468, 2019 | 20 | 2019 |
| FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype KM Levine, N Priedigkeit, A Basudan, N Tasdemir, MJ Sikora, ES Sokol, ... NPJ breast cancer 5 (1), 1-5, 2019 | 13 | 2019 |
| Tumor resection guided by intraoperative indocyanine green dye fluorescence angiography results in negative surgical margins and decreased local recurrence in an orthotopic … A Mahjoub, A Morales-Restrepo, MS Fourman, JB Mandell, L Feiqi, ... Annals of surgical oncology 26 (3), 894-898, 2019 | 11 | 2019 |
| To bind or not to bind-FoxA1 determines estrogen receptor action in breast cancer progression RJ Watters, PV Benos, S Oesterreich Breast cancer research 14 (3), 1-2, 2012 | 10 | 2012 |
| Disulfiram reduces metastatic osteosarcoma tumor burden in an immunocompetent Balb/c or-thotopic mouse model JA Crasto, MS Fourman, A Morales-Restrepo, A Mahjoub, JB Mandell, ... Oncotarget 9 (53), 30163, 2018 | 9 | 2018 |
| Acoustic emission generation from water flow through granular soils CJ Buck, RJ Watters Proceedings of the 22nd Symp. on Eng. Geol. and Soils Eng, 138-154, 1986 | 6 | 1986 |
| A Novel Sulforaphane-Regulated Gene Network in Suppression of Breast Cancer–Induced Osteolytic Bone Resorption SK Pore, ER Hahm, SH Kim, KB Singh, L Nyiranshuti, JD Latoche, ... Molecular cancer therapeutics 19 (2), 420-431, 2020 | 4 | 2020 |
| Combination therapy with disulfiram, copper, and doxorubicin for osteosarcoma: in vitro support for a novel drug repurposing strategy JB Mandell, F Lu, M Fisch, JH Beumer, J Guo, RJ Watters, KR Weiss Sarcoma 2019, 2019 | 4 | 2019 |
Kurt WeissAssistant Professor, University of Pittsburgh School of MedicineVerified email at upmc.edu
